BLTE Stock Analysis: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$170.35
1.35 (0.80%)
▲
5d:
+4.85%
30d:
+6.5%
90d:
+73.65%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLTE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BLTE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $170.35, which is considered extended relative to its 30-day fair value range of $155.82 to $166.10.
Technical Outlook: Technically, BLTE is in a strong uptrend. The price is approaching resistance at $174.78. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $186.50 (+10.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLTE is in a strong uptrend. The price is approaching resistance at $174.78. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $186.50 (+10.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$155.82 -
$166.10
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.4%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($186.50)
Fair Price Analysis
30-Day Fair Range
$155.82 -
$166.10
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$150.00
Resistance Level
$174.78
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-151.28
Wall Street Target
$186.50
(+10.4%)
Last updated: February 02, 2026 10:34 AM ET
Data refreshes hourly during market hours. Next update: 11:34 AM
Data refreshes hourly during market hours. Next update: 11:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
